Montreal Clinical Research Institute

Montreal, Quebec QC H2W 1R7

0 studies enrolling now · 3 studies all time

What they study most

Chronic Kidney Diseases, Hereditary Angioedema

Studies at this site

• Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to Garadacimab — Completed
• Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks — Completed
• Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria — Completed